Balaji Gandhi Sells 864 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 864 shares of the business’s stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total transaction of $20,571.84. Following the transaction, the chief financial officer now directly owns 107,547 shares of the company’s stock, valued at approximately $2,560,694.07. This trade represents a 0.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Balaji Gandhi also recently made the following trade(s):

• On Tuesday, April 8th, Balaji Gandhi sold 8,045 shares of Phreesia stock. The shares were sold at an average price of $23.85, for a total transaction of $191,873.25.
• On Wednesday, March 26th, Balaji Gandhi sold 1,827 shares of Phreesia stock. The stock was sold at an average price of $27.46, for a total transaction of $50,169.42.
• On Tuesday, February 18th, Balaji Gandhi sold 5,771 shares of Phreesia stock. The stock was sold at an average price of $30.04, for a total value of $173,360.84.
• On Thursday, February 13th, Balaji Gandhi sold 28,759 shares of Phreesia stock. The shares were sold at an average price of $30.00, for a total value of $862,770.00.
• On Monday, January 27th, Balaji Gandhi sold 4,813 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total value of $132,261.24.
• On Tuesday, January 21st, Balaji Gandhi sold 5,827 shares of Phreesia stock. The shares were sold at an average price of $27.31, for a total value of $159,135.37.

Phreesia Stock Up 0.1 %

Shares of Phreesia stock opened at $23.92 on Friday. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The firm has a market capitalization of $1.41 billion, a PE ratio of -16.27 and a beta of 0.82. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock’s fifty day moving average is $26.07 and its 200-day moving average is $24.29.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on PHR shares. Piper Sandler reiterated an “overweight” rating and issued a $33.00 target price (up previously from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. KeyCorp decreased their price objective on shares of Phreesia from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Wednesday. Citigroup boosted their target price on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Canaccord Genuity Group increased their price target on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research note on Thursday, March 13th. Finally, DA Davidson dropped their price objective on Phreesia from $36.00 to $34.00 and set a “buy” rating on the stock in a research note on Monday, April 14th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat, Phreesia presently has a consensus rating of “Buy” and a consensus target price of $31.33.

Institutional Trading of Phreesia

Several institutional investors and hedge funds have recently bought and sold shares of PHR. QRG Capital Management Inc. increased its position in shares of Phreesia by 8.0% in the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company’s stock worth $284,000 after acquiring an additional 827 shares in the last quarter. SG Americas Securities LLC acquired a new position in Phreesia in the 1st quarter worth approximately $462,000. Rhumbline Advisers boosted its stake in Phreesia by 3.8% in the 1st quarter. Rhumbline Advisers now owns 86,844 shares of the company’s stock worth $2,220,000 after purchasing an additional 3,213 shares during the period. GAMMA Investing LLC grew its position in Phreesia by 10,605.7% during the 1st quarter. GAMMA Investing LLC now owns 5,674 shares of the company’s stock worth $145,000 after purchasing an additional 5,621 shares in the last quarter. Finally, Probity Advisors Inc. acquired a new stake in Phreesia during the 4th quarter valued at $304,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.